Bg pattern

IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Ibandronic Acid Kern Pharma 150 mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others, as it may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the pack:

  1. What is Ibandronic Acid Kern Pharma and what is it used for
  2. Before taking Ibandronic Acid Kern Pharma
  3. How to take Ibandronic Acid Kern Pharma
  4. Possible side effects
  5. Storing Ibandronic Acid Kern Pharma
  6. Further information

1. What is Ibandronic Acid Kern Pharma and what is it used for

Ibandronic Acid Kern Pharma belongs to a group of medicines called bisphosphonates, which contains ibandronic acid. It does not contain hormones.

Ibandronic acid can reverse bone loss as it prevents further bone loss and increases bone mass in most women who take it, even if they cannot see or feel the difference. Ibandronic acid may help reduce the risk of bone fractures. This reduction has been shown in spinal fractures but not in hip fractures.

You have been prescribed ibandronic acid to treat your osteoporosis because you are at high risk of fractures.Osteoporosis is a condition where the bones become thinner and weaker, often in women after the menopause. During the menopause, the ovaries stop producing the female hormone - estrogen - which helps maintain bone health.

The earlier a woman reaches menopause, the higher the risk of osteoporosis fractures. Other factors that increase the risk of fractures include:

  • inadequate intake of calcium and vitamin D in the diet
  • smoking or excessive alcohol consumption
  • little walking or other weight-bearing exercise
  • family history of osteoporosis

Many people with osteoporosis do not experience symptoms. If you do not have symptoms, it may be difficult to know if you have the condition. However, osteoporosis increases the risk of bone fractures in the event of a fall or injury. Any bone fracture that occurs after the age of 50 may be a sign of osteoporosis. Osteoporosis can also cause back pain, loss of height, and stooping.

Ibandronic acid prevents bone loss due to osteoporosis and helps rebuild bone. Therefore, Ibandronic Acid Kern Pharma reduces the risk of fractures.

Healthy lifestyle habitsalso facilitate the beneficial effects of treatment. These include a balanced diet rich in calcium and vitamin D; walking or any other weight-bearing exercise; not smoking; and moderate alcohol consumption.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before taking Ibandronic Acid Kern Pharma

Do not take Ibandronic Acid Kern Pharma:

  • If you are allergic (hypersensitive) to ibandronic acid or any of the other ingredients of Ibandronic Acid Kern Pharma.
  • If you have certain esophageal problems (the esophagus is the tube that connects your mouth to your stomach), such as narrowing or difficulty swallowing.
  • If you cannot stay upright (standing or sitting) for at least one hour (60 minutes).
  • If you have low calcium levels in your blood. Please consult your doctor.

Do not give Ibandronic Acid Kern Pharma to children or adolescents.

Be careful with Ibandronic Acid Kern Pharma

Some people require special care during treatment with ibandronic acid. Consult your doctor:

  • If you have any mineral metabolism disorder (e.g., vitamin D deficiency).
  • If you have kidney problems.
  • If you have swallowing or digestive problems.
  • If you are undergoing dental treatment or plan to have dental surgery, inform your dentist that you are being treated with ibandronic acid.

Irritation, inflammation, or ulceration of the esophagus (the esophagus is the tube that connects your mouth to your stomach) may occur, often with symptoms of severe chest pain, severe pain after swallowing food and/or drink, severe nausea, or vomiting, especially if patients do not drink a full glass of water and/or lie down before one hour has passed after taking ibandronic acid. If you develop these symptoms, stop taking Ibandronic Acid Kern Pharma and inform your doctor immediately.

A rare adverse reaction called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported during post-marketing experience in patients treated with Ibandronic Acid Kern Pharma for osteoporosis. ONJ can also occur after stopping treatment.

It is essential to try to prevent the development of ONJ, as it is a painful condition that can be challenging to treat. To reduce the risk of developing osteonecrosis of the jaw, certain precautions must be taken.

Before receiving treatment, inform your doctor/nurse (healthcare professional) if:

  • you have mouth or tooth problems, such as poor dental health, gum disease, or a planned tooth extraction.
  • if you do not receive routine dental care or if you have not had a dental check-up for a long time.
  • if you are a smoker (as this can increase the risk of dental problems).
  • if you have been previously treated with a bisphosphonate (used to treat or prevent bone disorders).
  • if you are taking medications called corticosteroids (such as prednisolone or dexamethasone).
  • if you have cancer.

Your doctor may ask you to undergo a dental examination before starting treatment with Ibandronic Acid Kern Pharma.

While being treated, you must maintain good oral hygiene (including regular toothbrushing) and undergo routine dental check-ups. If you wear dentures, ensure they fit properly. If you are undergoing dental treatment or plan to have dental surgery (e.g., tooth extraction), inform your doctor about your dental treatment and inform your dentist that you are being treated with Ibandronic Acid Kern Pharma.

Contact your doctor and dentist immediately if you experience any mouth or tooth problems, such as tooth loss, pain, or swelling, or difficulty healing ulcers or discharge, as these may be signs of osteonecrosis of the jaw.

This medicine contains lactose as an excipient

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

This medicine contains sodium as an active ingredient

This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is essentially "sodium-free".

Using other medicines

Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription. Especially:

  • Supplements containing calcium, magnesium, iron, or aluminum, as they may affect the effects of ibandronic acid.
  • Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) (such as ibuprofen, diclofenac sodium, and naproxen), which can irritate the stomach and intestines, as well as bisphosphonates (such as ibandronic acid). Therefore, be careful when taking pain relievers or anti-inflammatory medications at the same time as Ibandronic Acid Kern Pharma.

After taking the monthly ibandronic acid tablet, wait 1 hour before taking any other medicine,including antacids, calcium supplements, and vitamins.

Taking Ibandronic Acid Kern Pharma with food and drinks:

Do not take ibandronic acid with food.Ibandronic acid loses effectiveness if taken with food.

You can drink tap water but not other liquids(see section 3. HOW TO TAKE IBANDRONIC ACID KERN PHARMA).

Pregnancy and breastfeeding

Do not take ibandronic acid if you are pregnant or breastfeeding. If you are breastfeeding, you may need to stop breastfeeding to take ibandronic acid.

Driving and using machines

It is unlikely that ibandronic acid will affect your ability to drive or use machines.

Important information about some of the ingredients of Ibandronic Acid Kern Pharma

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

3. How to take Ibandronic Acid Kern Pharma

Follow the instructions for taking ibandronic acid that your doctor has given you. Ask your doctor or pharmacist if you have any questions.

The usual dose of Ibandronic Acid Kern Pharma is one tablet per month.

How to take the monthly tablet

It is essential to follow these instructions carefully. They are designed to ensure that ibandronic acid reaches the stomach quickly and causes less irritation.

  • Take one Ibandronic Acid Kern Pharma tablet once a month.
  • Choose a day of the month that is easy for you to remember. You can choose the same date (e.g., the first day of each month) or always the same day (e.g., the first Sunday of each month). Choose what best fits your routine.
  • Take the ibandronic acid tablet after a minimum of 6 hours of not eating or drinking (except water). You can only drink water during this period.
  • Take the ibandronic acid tablet
  • as soon as you get up, and
  • before breakfast or drinking (on an empty stomach).
  • Swallow the tablet with a glass of tap water(at least 180 ml).

Do nottake the tablet with mineral water, fruit juice, or other drinks.

  • Swallow the tablet whole.

Do notchew, crush, or dissolve it in your mouth.

  • During the next hour (60 minutes)after taking the tablet
  • do not lie down; if you do not stay upright (standing or sitting), part of the medicine may come back up into the esophagus
  • do not eat anything
  • do not drink anything (except tap water, if needed)
  • do not take any other medicine
  • After waiting 1 hour, you can have breakfast and your first drink of the day. Once you have eaten, you can lie down and take any other medicines you need.

Do nottake this medicine at bedtime or before getting up.

Continuing treatment with Ibandronic Acid Kern Pharma

It is essential to take ibandronic acid every month, until your doctor tells you to stop.

Ibandronic Acid Kern Pharma only works to treat osteoporosis while you are taking this medicine.

If you take more Ibandronic Acid Kern Pharma than you should

If you have taken an extra tablet by mistake, drink a full glass of milk and inform your doctor immediately.

Do not induce vomiting or lie downas this may irritate the esophagus.

In case of overdose or accidental ingestion, call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Ibandronic Acid Kern Pharma

If you forget to take the tablet on the morning of the day you have chosen, do not take the tablet later.Instead, consult your calendar to see when your next dose is due:

If your next dose is due in1 to7 days…

Wait until your next scheduled dose and take it as usual, then continue taking one tablet per month according to the days marked on your calendar.

If your next dose is due in more than 7 days…

Take a tablet the next morning after the day you remember you forgot the dose, then continue taking one tablet per month according to the days marked on your calendar.

Never take two ibandronic acid tablets within the same week.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Ibandronic Acid Kern Pharma can cause side effects, although not everyone gets them.

These side effects may occur with certain frequencies, which are defined below:

  • very common: affects more than 1 in 10 people
  • common: affects between 1 and 10 in 100 people
  • uncommon: affects between 1 and 10 in 1,000 people
  • rare: affects between 1 and 10 in 10,000 people
  • very rare: affects less than 1 in 10,000 people
  • unknown: the frequency cannot be estimated from the available data

Common side effectsinclude heartburn (burning sensation rising from the stomach to the mouth), indigestion, diarrhea, stomach pain, and nausea.

Ibandronic acid can also irritate the esophagus, although this reaction is usually avoided if the dose is taken according to the package leaflet.If you experience symptoms such as severe chest pain, severe pain after swallowing food or drink, nausea, or vomiting, stop taking ibandronic acid and inform your doctor immediately.

Other common side effects include rash, muscle cramps, muscle and joint pain, and headache.

They also include flu-like symptoms (such as pain, feeling unwell, fatigue) that are usually mild, short-lived, and disappear soon after taking the first dose. It is likely that you can tolerate them and continue treatment with ibandronic acid. However, talk to your doctor if the effects worsen or last a long time.

Uncommon side effects are dizziness, back pain, flatulence, and symptoms of low calcium levels in the blood (hypocalcemia), including muscle cramps or spasms and/or tingling sensation in the fingers or around the mouth.

Rare side effects that may occur are swelling and itching of the face, lips, and mouth.

Atypical fractures of the femur (thigh bone) can occur rarely, especially in patients on long-term treatment for osteoporosis. Inform your doctor if you notice pain, weakness, or discomfort in the thigh, hip, or groin, as these may be early symptoms of a possible femur fracture.

Very rare side effects: Consult your doctor if you experience ear pain, discharge from the ear, or an ear infection. These could be symptoms of damage to the bones of the ear.

Reporting side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Ibandronic Acid Kern Pharma

Keep out of sight and reach of children.

No special storage conditions are required.

Do not use after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for proper disposal. Ask your pharmacist how to dispose of medicines no longer needed. This will help protect the environment.

6. Further information

Composition of Ibandronic Acid Kern Pharma

  • Each tablet contains 150 mg of ibandronic acid (as ibandronate sodium monohydrate).
  • The other ingredients are: cornstarch, microcrystalline cellulose (E-460i), crospovidone (E1202), glycerol behenate, povidone (E1201), and colloidal silicon dioxide in the core of the tablet, and titanium dioxide (E-171), hypromellose (E-464), lactose monohydrate, and macrogol in the coating.

Appearance and packaging of the product:

Ibandronic Acid Kern Pharma tablets are white, round, and biconvex.

Ibandronic Acid Kern Pharma is available in blister packs of 1 and 3 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Kern Pharma, S.L.

Venus, 72 – Pol. Ind. Colón II

08228 Terrassa - Barcelona

Spain

Manufacturer

Pharmathen, S.A

6, Dervenakion Str - GR-16351 (Pallini Attikis)

Greece

Date of last revision of this package leaflet: June 2022

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS

Discuss questions about IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS?
IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS?
The active ingredient in IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS is ibandronic acid. This information helps identify medicines with the same composition but different brand names.
How much does IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS is around 13 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS?
IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to IBANDRONIC ACID KERN PHARMA 150 mg FILM-COATED TABLETS?
Other medicines with the same active substance (ibandronic acid) include ABRION 150 mg FILM-COATED TABLETS, Ibandronic Acid Accord 2 mg concentrate for infusion solution, Ibandronic Acid Accord 6 mg concentrate for infusion solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media